2021 CRI Meeting Abstracts

First Place

Electronic Source Documentation in Epic Reduces Key Audit Findings and Aids in Remote Coordinating and Auditing [Abstract] [Poster]
N. Kurtzweil, M. Marcum, T. Wise-Draper
University of Cincinnati Cancer Center 

Second Place

A Catalyst for Success: How the I2T3 is Transforming IIT Development at UFHCC [Abstract] [Poster]
A. Anderson, E. Monari, A. Ivey, T. George
University of Florida Health Cancer Center

Third Place

Doing More With Less: The Adoption of Slot Management Practices to Drive Resource Allocation in the Clinical Trials Office [Abstract] [Poster]
C. Gregor
Vanderbilt-Ingram Cancer Center
 


Abstracts are organized by category, in alphabetical order by cancer center.
 

Categories:
Clinical Trial Operations
Finance/CCSG/PRMS
Investigator-Initiated Trials
Regulatory
Training, Quality Assurance, Remote Monitoring, and Auditing
Trial Recruitment & Community Outreach and Engagement
Trial Start-up and Activation

 

Clinical Trial Operations
1. Operationalizing a New Therapy Across Research Groups: A Team-Based Approach to Managing CAR T Clinical Trials [Abstract] [Poster]
L. Waitkus
Cleveland Clinic Cancer Center

2. COVID Response: Providing Ongoing Oncology Clinical Research Support During a Pandemic [Abstract] [Poster]
B. Oleson, J. Thomas, J. Bollmer, K. Schroeder, D. Pastorek, P. Jacobs, M. Pigsley, S. Zindars, G. Coly
Medical College of Wisconsin Cancer Center

3. Automating Protocol Training Documentation: Regulatory Compliance in a Click [Abstract] [Poster]
R. Lehrman, P. Lim, C. Abate, J. Buthorn, A. Foster, E. Hamilton, H. Kiesler, K. Yataghene
Memorial Sloan Kettering Cancer Center

4. Clinical Trial Finder - A Comprehensive Mobile Application [Abstract] [Poster]
D. Mudaranthakam, V. Murakonda, A. Tribitt, J. Scott, B. Broome, J. Thompson, M. Mayo, B. Gajewski, T. Lin
The University of Kansas Cancer Center

5. OPTIK - Organize Prioritize Trends to Inform KU Cancer Center Members [Abstract] [Poster]
D. Mudaranthakam, L.M. Harlan-Williams, H. Krebill, H. Kuo, D. Koestler, Q. Xia, R. Chen, L. Chollet-Hinton, M. Mayo, R. Jensen
The University of Kansas Cancer Center

6. Cross Modality Reconciliation for Management and Reporting of All Cancer Related Clinical Research Data [Abstract] [Poster]
C. Serway, E.D. Merchasin, R.C. Compton, U. Brown-Glaberman, C.Y. Muller
University of New Mexico Comprehensive Cancer Center

7. We Have 99 Problems But a Participant Withdraw is No Longer One [Abstract] [Poster]
S. Bigelow, C. Galasso, J. Ventimiglia, L. Casetta, C. Zuccaro, J. Mancini
Barbara Ann Karmanos Cancer Institute, Wayne State University

8. Executing a Healthy Volunteer Study During COVID-19 Pandemic [Abstract] [Poster]
P. Herena, M. Licata, R. Stan, C. Wood, A. Yi, M. Shields
City of Hope Comprehensive Cancer Center

9. Increasing the Utilization and Efficiency of a Phase 1 Program to Support Pan-Tumor Clinical Trials [Abstract] [Poster]
J. Tomer, K. Gardner, J. Southard
Cleveland Clinic Cancer Center

10. Harness the Power of Automation for Clinical Research Management [Abstract] [Poster]
D. Wilson, R. Kingsford, L. Hayes, J. Moehle, T. Werner
Huntsman Cancer Institute, University of Utah

11. A Quality Connection … An Enhanced Leadership Structure Through the Implementation of a Project Administrator [Abstract] [Poster]
L. Lujan, S. Sharry, R. Kingsford, J. Moehle
Huntsman Cancer Institute, University of Utah

12. Smooth Sailing... Cellular Immunotherapy Trials Collaboration and Integration Process [Abstract] [Poster]
S. Sharry, C. Cromar, K. Hicks, L. Lujan, J. Moehle, K. Pena
Huntsman Cancer Institute, University of Utah

13. Team Connection During COVID [Abstract] [Poster]
J. Espinosa, C. Marshall, A. Horstmeier, J. Moehle, L. Lujan
Huntsman Cancer Institute, University of Utah

14. * There and Back Again: A Satellite Site Operations Tale [Abstract] [Poster]
B. Glenn, K. Stephens, A. Horstmeier, E. D'Astous, J. Moehle, T. Werner
Huntsman Cancer Institute, University of Utah

15. Establishing an Employee Engagement, Equity, and Education Committee During Remote Operations [Abstract] [Poster]
J. Feola, M. Kimber, A. Hoeschen, M. Dworak, M. Loza
Masonic Cancer Center, University of Minnesota

16. Transformative Lessons for Clinical Trials From the COVID-19 Pandemic: Remote Monitoring, Virtual Research Visits, and Added Flexibility for Patients [Abstract] [Poster]
G. Malave, A. Fritsche, K. Croghan, J. Jensen, J. Burton, J. Pickett, H. Finnes, J. Judge, J. Bruggeman, J. Welter, S. Alberts, S. Kumar
Mayo Clinic Cancer Center

17. Structured Collaboration with Clinical Partners to Enhance Research Participant Safety and Experience Along with Protocol Compliance and Expeditious Trial Activation [Abstract] [Poster] 
S. Willoughby, C. Davis
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

18. Incorporating the Complexity of Screening into Protocol Acuity: Updates to the SCCC Staff Scoring Model [Abstract] [Poster]
E. Siglinsky, K. Crane, S. Grant, S. Meletath, A. Neal, H. Phan, S. Goksu, M.S. Beg, E. Williams
Simmons Comprehensive Cancer Center, UT Southwestern Medical Center

19. Does Mentorship Improve CRC Retention Rates and Employee Satisfaction? [Abstract] [Poster]
E. Pon, E. Nurminen, M. Welsh, M. Narwal
UCSF Helen Diller Family Comprehensive Cancer Center

20. Transitioning to Remote Monitoring Visits at the Helen Diller Family Comprehensive Cancer Center [Abstract] [Poster]
M. Kock
UCSF Helen Diller Family Comprehensive Cancer Center

21. From Take-Off to Landing: The Creation and Implementation of a CCPS Navigator Resource [Abstract] [Poster]
A. Trainor, A. Ivey, T. George, L. Pettiford, A. Anderson
University of Florida Health Cancer Center

22. Implementation of Electronic Informed Consent for Cancer-Relevant Clinical Trials at the UFHCC [Abstract] [Poster]
A. Riggs, T. Toon, A. Anderson, A. Ivey, T. George
University of Florida Health Cancer Center

23. Doing More With Less: The Adoption of Slot Management Practices to Drive Resource Allocation in the Clinical Trials Office [Abstract] [Poster]
C. Gregor
Vanderbilt-Ingram Cancer Center

24. Adapting Adverse Event Log Creation During COVID-19: Development of the Winship eAE Log Application [Abstract] [Poster]
D. Smith, M. Ellingson, V. Parker, M. Martin, T. Adewuya, P. Bourbo, S. Brown, L. Cox, M. Williams, L. Floyd, B. Gamble, M. Hananel, T. Kurilo, A. Lesinski, K. Nguyen, C. Shah, C. Sharp, A. Trumbull, A. Overby, M. Behera
Winship Cancer Institute of Emory University

Back to top

Finance/CCSG/PRMS

25. Staff Effort Estimate Calculator: A Successful Multisite Program Budget and Staffing Tool [Abstract] [Poster]
A. Hinman, A. Baim, A. Carabajal, R. Selle, B. Oleson, J. Thomas

Medical College of Wisconsin Cancer Center

26. Statistically Significant Impacts of a PRMC Charter Alignment With NCI Practices [Abstract] [Poster]
C. Vollmer, T. Herzog, C. Allen, N. Kurtzweil, E. Chandra, B. Hughes

University of Cincinnati Cancer Center

27. * MSK’s NCI Network Program [Abstract] [Poster]
J. Mohr, L. Gaffney, C. Houston, M. Warren, C. Aghajanian, P. Sabbatini, E. Cottington, S. Ramaswami, B. Zakrzewski, J. Klinger, S. Dominguez, S. Terzulli, J. Nunner, A. Rodavitch, K.R. Simpson, S. Hanley

Memorial Sloan Kettering Cancer Center

28. Enhancing the DSG Review at the UFHCC [Abstract] [Poster]
J. Walsh, T. Guinn, A. Anderson, A. Ivey, T. George

University of Florida Health Cancer Center

Back to top

Investigator-Initiated Trials

29. * Use of R-Scripts Can Help to Decrease Time and Improve Accuracy on Summary Tables for IND and Semi-Annual Reports [Abstract] [Poster]
B. Palmer, A. Brikha, F. Lin, J. Woodman

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

30. Managing Investigator Initiated Clinical Trials Registration to Reduce Overall Reporting Errors at a Consortium Cancer Center [Abstract] [Poster]
K. Hoy, A. Savadelis, A. Firstencel, H.J. Pounardjian

Case Comprehensive Cancer Center

31. Development, Management and Oversight of Investigator-initiated Multicenter Trials [Abstract] [Poster]
J. Walkley, M. Warren, K. Muenkel, S. Hughes, C. Friedman, C. Houston

Memorial Sloan Kettering Cancer Center

32. A Catalyst for Success: How the I2T3 is Transforming IIT Development at UFHCC [Abstract] [Poster]
A. Anderson, E. Monari, A. Ivey, T. George

University of Florida Health Cancer Center

Back to top

Regulatory

33. Implementation of a Fully Electronic Regulatory Binder for Clinical Trials During COVID Pandemic [Abstract] [Poster]
C. Kennedy, B. Sharp, K. Penas
Fred and Pamela Buffett Cancer Center

34. Fast Financials: An Automated Approach to Financial Disclosures [Abstract] [Poster]
A. Foster, J. Buthorn, A.M. Gonzalez-Dadiz, K. Yataghene
Memorial Sloan Kettering Cancer Center

35. Regulatory Team Increasing Efficiency and Reducing Footprint in the Office [Abstract] [Poster]
C. Vollmer
University of Cincinnati Cancer Center

36. Partnering With Foreign Collaborators and the Institutional Review Board to Document Human Subjects Protection Requirements for Sites Outside of the United States [Abstract] [Poster]
V. Santana, L. Faughnan, E. Fernandes, K. Prive, P. Naidu
Comprehensive Cancer Center St. Jude Children's Research Hospital

37. * Developing a Tool to Assess Regulatory Acuity and Workload [Abstract] [Poster]
M. Kannon, S. Scott
UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

38. Regulatory Completion Timelines: A Prospective and Retrospective Analysis of the Effect of an eRegulatory System [Abstract] [Poster]
M. Kannon, S. Scott, J. Sweitzer, K.M.C. Blalock, P. Brock, A. Ciccotti, S. Williams, C. Worth
UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

39. Implementing the Shared Investigator Platform at the UFHCC [Abstract] [Poster]
A. Anderson, T. Toon, A. Ivey, T. George
University of Florida Health Cancer Center

Back to top

Training, Quality Assurance, Remote Monitoring, and Auditing

40. Maintaining Specimen Compliance for a High Volume of Complex Clinical Trials [Abstract] [Poster]
C. Johnston, A. Larsen, J. Cummings, J. Moehle

Huntsman Cancer Institute, University of Utah
 

41. Risk-Based Monitoring (RBM) Model: Safeguarding Single-Center, Investigational New Drug (IND), Investigator-Initiated Trials (IIT) at Memorial Sloan Kettering Cancer Center [Abstract] [Poster]
F. Puma, A. Granobles, K. Mantha-Thaler, K. Yataghene

Memorial Sloan Kettering Cancer Center

42. Saved by Automation! How Technology and Innovative Thinking Significantly Increased Productivity of the MSK CR Audit Program [Abstract] [Poster]
S. Puleio, J. Simpronio

Memorial Sloan Kettering Cancer Center

43. Strengthening Monitoring/Auditing Collaboration With Sponsors [Abstract] [Poster]
A. Granobles, F. Puma, K. Yataghene, K. Mantha-Thaler, N. Cimaglia
Memorial Sloan Kettering Cancer Center

44. Demonstrating Safety and Necessity of Clinical Trials Deviations for Improving Flexibility and Inclusivity of Clinical Trials Enrollment Utilizing a Centralized Deviation Database [Abstract] [Poster]
M. Hullings, E. Williams, P. Dixit, C. Wynne-Jones, A. Gonzalez, M.S. Beg, D. Gerber

Simmons Comprehensive Cancer Center, UT Southwestern Medical Center

45. Creation of a Sponsor Quality Management Plan Under GCP revision 2: Check-and-Balances, Quality Systems, and Cross-Functional Communication [Abstract] [Poster]
J. Morrison, M. O'Dwyer, C. Conde, S. Maxwell, N. Babadi, R. Johnson, M.A. Kannon, S. Scott, J. Huamani-Bundy, C. Lee

UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

46. Electronic Source Documentation in Epic Reduces Key Audit Findings and Aids in Remote Coordinating and Auditing [Abstract] [Poster]
N. Kurtzweil, M. Marcum, T. Wise-Draper

University of Cincinnati Cancer Center

47. Remote Onboarding and Training in the Clinical Trials Office [Abstract] [Poster]
K. Rygalski, M. Russell, D. Kitterman

University of Illinois Cancer Center

48. Reducing Turnover During a Pandemic: Growing Leaders at an NCI-Designated Cancer Center [Abstract] [Poster]
A. Rice-Warren, C. Fournier

Duke Cancer Institute, Duke University Medical Center

49. Transitioning to Remote Monitoring: Challenges and Successes [Abstract] [Poster]
H. Finch, S. Matkin, K. Thorne

Huntsman Cancer Institute, University of Utah

50. * Equity and Diversity Initiatives Within a Cancer Center's Clinical Trials Office [Abstract] [Poster]
M. Dworak, M. Loza, D. Berkow-Schwartz

Masonic Cancer Center, University of Minnesota

51. Rolling With the Changes: Onboarding Staff Remotely During the COVID-19 Pandemic [Abstract] [Poster]
R. Selle, M. Gray, B. Oleson, J.P. Thomas
Medical College of Wisconsin Cancer Center

52. Onboarding and Training New Staff While Working Remote During a Global Pandemic [Abstract] [Poster]
E. Laskowski, J. DeJong, H. Apell

The University of Kansas Cancer Center

53. Ensuring the Next Generation of Clinical Researchers [Abstract] [Poster]
A. Anderson, L. Pettiford, A. Ivey, T. George

University of Florida Health Cancer Center

54. Implementation of a Research-specific, Electronic Orientation for Clinical Research Professionals [Abstract] [Poster]
A. Kukulka, A. Ivey, A. Anderson, T. George

University of Florida Health Cancer Center

55. Implementation of Professional Competency Development Program for Clinical Research Professionals [Abstract] [Poster]
A. Kukulka, A. Ivey, A. Anderson, T. George

University of Florida Health Cancer Center

Back to top

Trial Recruitment & Community Outreach and Engagement 

56. * Exploring the Perceptions and Satisfaction of Princess Margaret Clinical Trial Participants [Abstract] [Poster]
K. Zeman, S. Sellmann, H. Cole
Princess Margaret Cancer Centre, University Health Network

57. Strengthening Connections: Integrating Clinical Trials into Patient and Public Education [Abstract] [Poster]
G. Nachaegari, S. Fraser, D. Branson, J. Moehle, T. Werner
Huntsman Cancer Institute, University of Utah

Back to top

Trial Start-up and Activation

58. Use of a Site Profile to Streamline Site Selection and Feasibility [Abstract] [Poster]
S. Zindars, J. Bollmer, B. Oleson, K. Schroeder, D. Pastorek, M. Pigsley, P. Jacobs, G. Coly, R. Selle, B. Steinert, A. Carabajal
Medical College of Wisconsin Cancer Center

59. One Committee to Review Them All: A Single, Multidisciplinary COVID-19 Research Committee [Abstract] [Poster]
J. Migliacci, S. Hanley, A. Rodavitch
Memorial Sloan Kettering Cancer Center

60. Study Start-up Activation Dashboard - Improving Transparency [Abstract] [Poster]
L. Wall, A. Spratt, N. Connellan
The University of Chicago Medicine Comprehensive Cancer Center

61. * Strategies for Improving Time-to-Activation of Clinical Trials [Abstract] [Poster]
J. Plassmeyer, B. Marino, M. Horak, H. Usman, D. Cleary, B. Pappu, A. Wozniak
UPMC Hillman Cancer Center

62. Process Improvements to Shorten Clinical Trial Activation Times Within a National Cancer Center Designated Comprehensive Cancer Center [Abstract] [Poster]
S. Grant, M. Farmer
Wake Forest Baptist Comprehensive Cancer Center

Back to top

*Honorable Mention